Stock 000963 HUADONG MEDICINE CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Huadong Medicine Co., Ltd Stock

Equities

000963

CNE0000011S1

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-25 EDT 		5-day change 1st Jan Change
32.77 CNY +0.06% Intraday chart for Huadong Medicine Co., Ltd +4.03% -20.96%
04-25 Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-18 Huadong Medicine's 2023 Profit Jumps 14% MT

Financials

Sales 2024 * 45.49B 6.28B 8.58B Sales 2025 * 49.96B 6.9B 9.42B Capitalization 57.35B 7.92B 10.82B
Net income 2024 * 3.29B 454M 620M Net income 2025 * 4.13B 570M 779M EV / Sales 2024 * 1.17 x
Net cash position 2024 * 3.97B 548M 749M Net cash position 2025 * 6.09B 840M 1.15B EV / Sales 2025 * 1.03 x
P/E ratio 2024 *
17.5 x
P/E ratio 2025 *
13.9 x
Employees 16,969
Yield 2024 *
1.63%
Yield 2025 *
1.84%
Free-Float 41.86%
More Fundamentals * Assessed data

Chart Huadong Medicine Co., Ltd

Dynamic Chart

Latest news about Huadong Medicine Co., Ltd

Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Huadong Medicine's 2023 Profit Jumps 14% MT
Huadong Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China's first biosimilar Ozempic drug applies for approval RE
Huadong Medicine to Build 2 Billion Yuan Biopharma Innovation Center MT
Huadong Medicine to Invest 2 Billion Yuan in Biopharma Innovation Center MT
Huadong Medicine's 2023 Profit to Climb Up to 14.5% MT
Huadong Medicine Eyes Exclusive Marketing Rights for Cancer Drug Senaparib in China for 290 Million Yuan MT
Huadong Medicine's Unit Gains Chinese Drug Regulator's Nod to Trial Sirolimus Oral Solution MT
Chongqing Yuyan Pharmaceutical Co., Ltd. announced that it has received CNY 300 million in funding from Huadong Medicine Co., Ltd, Hangzhou State Capital Investment And Operations Co., Ltd., Hangzhou Gongshu State Investment Industry Development Co., Ltd. CI
Huadong Medicine's Unit, Partners to Invest in Pharmaceutical Firm CI
Huadong Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Huadong Medicine's Unit Gets Nod to Test Weight Management Drug; Shares Up 3% MT
Huadong Medicine Enters Exclusive Licensing Agreement with Denmark’s MC2 MT
Huadong Medicine’s H1 Profit Rises 7%; EPS, Revenue Miss Forecasts MT
More news

Press releases Huadong Medicine Co., Ltd

MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzora Cream in Greater China AQ
CARsgen Announced 2023 Interim Results AQ
Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia AQ
CARsgen Announced 2022 Annual Results and Business Updates AQ
Ad hoc announcement inside information pursuant to Article 17 MAR Heidelberg Pharma AG Announces Adjustment of Guidance AQ
More press releases

News in other languages on Huadong Medicine Co., Ltd

El primer medicamento chino bioequivalente a Ozempic solicita su aprobación
Weniger chinesische Übernahmen in Deutschland und Europa - Studie
More news

Quotes and Performance

1 day+0.06%
1 week+4.03%
Current month+5.71%
1 month+6.67%
3 months+3.83%
6 months-23.60%
Current year-20.96%
More quotes

Highs and lows

1 week
31.94
Extreme 31.94
33.35
1 month
28.90
Extreme 28.9
33.35
Current year
27.60
Extreme 27.6
41.45
1 year
27.60
Extreme 27.6
46.43
3 years
27.60
Extreme 27.6
53.94
5 years
16.02
Extreme 16.02
53.94
10 years
12.29
Extreme 12.2889
53.94
More quotes

Managers and Directors - Huadong Medicine Co., Ltd

Managers TitleAgeSince
Hong Lan Ma DFI
 Director of Finance/CFO 53 -
Bang Liang Li CHM
 Chairman 78 71-12-31
Dong Zhou Liu CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Bang Liang Li CHM
 Chairman 78 71-12-31
Wei Kang BRD
 Director/Board Member 56 -
Liang Lü CEO
 Chief Executive Officer 50 10-03-31
More insiders

ETFs positioned on Huadong Medicine Co., Ltd

Name Weight AuM 1st Jan change Investor Rating
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD ETF KraneShares MSCI All China Health Care Index UCITS ETF - USD
1.41% 2 M€ -16.59% -
KRANESHARES EMERGING MARKET HEALTHCARE INDEX ETF - DISTRIBUTING - USD ETF KraneShares Emerging Market Healthcare Index ETF - Distributing - USD
0.99% 2 M€ -14.14%
More ETFs positioned on Huadong Medicine Co., Ltd

Quotes

Date Price Change Volume
24-04-26 32.77 +0.06% 17,618,520
24-04-25 32.75 +1.08% 16,562,600
24-04-24 32.4 -1.79% 13,358,980
24-04-23 32.99 +3.68% 20,709,810
24-04-22 31.82 +1.02% 13,485,220

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes

Company Profile

Huadong Medicine Co., Ltd. specializes in the development, manufacture and marketing of medical products and vaccines. The products are intended primarily for the treatment of tumors, immune disorders, endocrine disorders, orthopedic and traumatological disorders, digestive system diseases and viral diseases.
Sector
Pharmaceuticals
Calendar
2024-05-08 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Ratings for Huadong Medicine Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
32.77 CNY
Average target price
47.92 CNY
Spread / Average Target
+46.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-1.22% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
H. LUNDBECK A/S Stock H. Lundbeck A/S
-0.18% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.89% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+7.96% 3.29B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 000963 Stock